Chien-wei L. Su
No. 201, Sec. 2, Shih Pai Road
Taipei, TNQ 11217, Taiwan
Taipei, TNQ 11217, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 198 publications
Reply to: "Comparison of patients with HBV-related HCC with and without MASLD after liver transplantation".
Journal: JHEP reports : innovation in hepatology
Published: June 22, 2026
Publisher Correction: Machine Learning Models for Predicting Significant Liver Fibrosis in Patients with Severe Obesity and Nonalcoholic Fatty Liver Disease.
Journal: Obesity surgery
Published: May 05, 2026
Inflammatory Gene Expression, Insulin Resistance, and Circulating Markers Vary by Visceral Adiposity in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: Metabolic syndrome and related disorders
Published: March 10, 2026
Editorial: Tumour Burden Score and Extrahepatic Progression After TACE-Refining Risk Stratification Beyond the Liver.
Journal: Alimentary pharmacology & therapeutics
Published: January 24, 2026
Interactive Roles of Metabolic Dysfunction-Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection.
Journal: The Kaohsiung journal of medical sciences
Published: January 24, 2026
Efficacy of CPAP Therapy on Liver Steatosis and Insulin Resistance in Fatty Liver Patients With Obstructive Sleep Apnea: A 4-Year Follow-Up Cohort Study.
Journal: The Kaohsiung journal of medical sciences
Published: December 29, 2025
Machine learning-based decision-tree model for patients with single-large hepatocellular carcinoma.
Journal: Journal of the Chinese Medical Association : JCMA
Published: December 08, 2025
Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels.
Journal: Journal of the Chinese Medical Association : JCMA
Published: October 22, 2025
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: August 15, 2025
Unravelling the heterogeneous HCC risk in indeterminate chronic hepatitis B.
Journal: Gut
Published: July 29, 2025
The frontline of metabolic dysfunction-associated steatotic liver disease: More to be discovered.
Journal: Journal of the Chinese Medical Association : JCMA
Published: July 08, 2025
Last Updated: 09/26/2026